Duke Criteria Calculator (2023 Duke-ISCVID)
Count majors and minors, get the classification — and keep the neurology in view: embolic stroke is often the presenting event of endocarditis, it counts as a vascular phenomenon, and it changes both thrombolysis and anticoagulation decisions.
Reviewed by Zaka Ahmed, MD Clinical reference · 4 min read
Duke-ISCVID Criteria
Select every criterion present. Classification: Definite = 2 major, or 1 major + 3 minor, or 5 minor. Possible = 1 major + 1 minor, or 3 minor. (Pathologic proof — positive histology or culture of a vegetation — is independently definite.)
The classification updates as you select criteria.
Educational tool only, using a condensed presentation of the 2023 Duke-ISCVID criteria; the full published criteria contain organism-specific and imaging-specific definitions that this summary cannot replace. Classification supports — never replaces — clinical diagnosis, echocardiography interpretation, and ID consultation.
Clinical notes & interpretation Scoring guidance, pitfalls, FAQs, and references
What changed in 2023
The Duke-ISCVID update modernized both arms of the criteria: the microbiologic major now includes enterococcal bacteremia without an obvious focus and PCR/serologic diagnosis of culture-negative organisms, and the imaging major finally admits what practice already knew — ¹⁸F-FDG PET/CT and cardiac CT findings can carry major-criterion weight, particularly around prosthetic material where echo struggles. The skeleton (2 major; 1 major + 3 minor; 5 minor for definite) survives from 1994 because it works.
Endocarditis is a stroke diagnosis until proven otherwise
A substantial minority of IE patients present neurologically — embolic infarcts (often multiple, multi-territory, small and cortical), mycotic aneurysms, ICH, or abscess — and the stroke service is frequently the first to meet them. Three operational rules follow. First, multi-territory embolic-appearing infarcts plus fever, murmur, bacteremia risk, or unexplained inflammatory markers should trigger blood cultures before antibiotics and an echocardiography pathway; the "vascular phenomena" minor criterion means the stroke itself is evidence. Second, IV thrombolysis in stroke from suspected IE is generally avoided — hemorrhage rates are high and the occlusions are septic material, not bland thrombus; mechanical thrombectomy is the reperfusion conversation instead. Third, anticoagulation does not treat the embolic risk of native-valve IE and raises hemorrhage risk in the presence of mycotic aneurysms and hemorrhagic transformation — existing anticoagulation usually gets held early, and antibiotics are what actually shrink embolic risk, most steeply in the first week of effective therapy.
Frequently asked questions.
Does an embolic stroke count toward the criteria?
Yes — cerebral emboli are a vascular phenomenon (minor criterion), as are intracranial hemorrhage and mycotic aneurysm. A classic presentation is 1 major (bacteremia) + stroke + fever + predisposition = definite IE.
Can tPA be given in stroke due to endocarditis?
It is generally avoided: reported hemorrhage rates are high, and septic emboli respond poorly to fibrinolysis. When a large-vessel occlusion is present, mechanical thrombectomy is the preferred reperfusion route. Practically, IE is usually unsuspected at the thrombolysis decision — which is why fever plus multi-territory infarcts should slow the syringe.
TTE or TEE first?
TTE first in most cases; TEE follows when TTE is nondiagnostic, when prosthetic material or CIED is present, or when suspicion stays high. The 2023 criteria let PET/CT and cardiac CT contribute where echo is limited.
References.
- Fowler VG, Durack DT, Selton-Suty C, et al. The 2023 Duke-ISCVID criteria for infective endocarditis: updating the modified Duke criteria. Clin Infect Dis. 2023;77(4):518–526. PubMed
- Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med. 1994;96(3):200–209. PubMed
- Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications — AHA scientific statement. Circulation. 2015;132(15):1435–1486. PubMed